Caxton Associates LP

SEC CIK: 0000872573
Latest filing: Feb 14, 2025

SEC filings (opens in a new tab)

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overview All 13F holders of NRIX Full Q4 2024 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of NRIX by Caxton Associates LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−30,767−100.0%	Sold out	Holders
Q2 2024	30,767	$642.1K	<0.1%	+15,453+100.9%	Added	Holders
Q1 2024	15,314	$225.1K	<0.1%	+15,314	New	Holders